AEON Biopharma
Newport Beach
About AEON Biopharma
AEON Biopharma is a biopharmaceutical company focused on the development of ABP-450, a proprietary 900 kDabotulinum toxin complex, for debilitating medical conditions. The company is dedicated to developing novel and proprietary treatment paradigms in order to improve patient outcomes and drive increased value for patients, physicians, and payers.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Total funding: $88.5M
- Funding stage: IPO
- Last round: Post-IPO Equity (Nov 2025)
- Ticker: nysemkt:AEON
- Website: aeonbiopharma.com
- Phone: +1-949-298-2211
Industries & Categories
Biotechnology, Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/aeon-biopharma-18714 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.